Cargando…

Monitoring HIV Drug Resistance Early Warning Indicators in Cameroon: A Study Following the Revised World Health Organization Recommendations

BACKGROUND: The majority (>95%) of new HIV infection occurs in resource-limited settings, and Cameroon is still experiencing a generalized epidemic with ~122,638 patients receiving antiretroviral therapy (ART). A detrimental outcome in scaling-up ART is the emergence HIV drug resistance (HIVDR),...

Descripción completa

Detalles Bibliográficos
Autores principales: Fokam, Joseph, Elat, Jean-Bosco N., Billong, Serge C., Kembou, Etienne, Nkwescheu, Armand S., Obam, Nicolas M., Essiane, André, Torimiro, Judith N., Ekanmian, Gatien K., Ndjolo, Alexis, Shiro, Koulla S., Bissek, Anne C. Z-K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471113/
https://www.ncbi.nlm.nih.gov/pubmed/26083364
http://dx.doi.org/10.1371/journal.pone.0129210
_version_ 1782376851031719936
author Fokam, Joseph
Elat, Jean-Bosco N.
Billong, Serge C.
Kembou, Etienne
Nkwescheu, Armand S.
Obam, Nicolas M.
Essiane, André
Torimiro, Judith N.
Ekanmian, Gatien K.
Ndjolo, Alexis
Shiro, Koulla S.
Bissek, Anne C. Z-K.
author_facet Fokam, Joseph
Elat, Jean-Bosco N.
Billong, Serge C.
Kembou, Etienne
Nkwescheu, Armand S.
Obam, Nicolas M.
Essiane, André
Torimiro, Judith N.
Ekanmian, Gatien K.
Ndjolo, Alexis
Shiro, Koulla S.
Bissek, Anne C. Z-K.
author_sort Fokam, Joseph
collection PubMed
description BACKGROUND: The majority (>95%) of new HIV infection occurs in resource-limited settings, and Cameroon is still experiencing a generalized epidemic with ~122,638 patients receiving antiretroviral therapy (ART). A detrimental outcome in scaling-up ART is the emergence HIV drug resistance (HIVDR), suggesting the need for pragmatic approaches in sustaining a successful ART performance. METHODS: A survey was conducted in 15 ART sites of the Centre and Littoral regions of Cameroon in 2013 (10 urban versus 05 rural settings; 8 at tertiary/secondary versus 7 at primary healthcare levels), evaluating HIVDR-early warning indicators (EWIs) as-per the 2012 revised World Health Organization’s guidelines: EWI(1) (on-time pill pick-up), EWI(2) (retention in care), EWI(3) (no pharmacy stock-outs), EWI(4) (dispensing practices), EWI(5) (virological suppression). Poor performance was interpreted as potential HIVDR. RESULTS: Only 33.3% (4/12) of sites reached the desirable performance for “on-time pill pick-up” (57.1% urban versus 0% rural; p<0.0001) besides 25% (3/12) with fair performance. 69.2% (9/13) reached the desirable performance for “retention in care” (77.8% urban versus 50% rural; p=0.01) beside 7.7% (1/13) with fair performance. Only 14.4% (2/13) reached the desirable performance of “no pharmacy stock-outs” (11.1% urban versus 25% rural; p=0.02). All 15 sites reached the desirable performance of 0% “dispensing mono- or dual-therapy”. Data were unavailable to evaluate “virological suppression” due to limited access to viral load testing (min-max: <1%-15%). Potential HIVDR was higher in rural (57.9%) compared to urban (27.8%) settings, p=0.02; and at primary (57.9%) compared to secondary/tertiary (33.3%) healthcare levels, p=0.09. CONCLUSIONS: Delayed pill pick-up and pharmacy stock-outs are major factors favoring HIVDR emergence, with higher risks in rural settings and at primary healthcare. Retention in care appears acceptable in general while ART dispensing practices are standard. There is need to support patient-adherence to pharmacy appointments while reinforcing the national drug supply system.
format Online
Article
Text
id pubmed-4471113
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-44711132015-06-29 Monitoring HIV Drug Resistance Early Warning Indicators in Cameroon: A Study Following the Revised World Health Organization Recommendations Fokam, Joseph Elat, Jean-Bosco N. Billong, Serge C. Kembou, Etienne Nkwescheu, Armand S. Obam, Nicolas M. Essiane, André Torimiro, Judith N. Ekanmian, Gatien K. Ndjolo, Alexis Shiro, Koulla S. Bissek, Anne C. Z-K. PLoS One Research Article BACKGROUND: The majority (>95%) of new HIV infection occurs in resource-limited settings, and Cameroon is still experiencing a generalized epidemic with ~122,638 patients receiving antiretroviral therapy (ART). A detrimental outcome in scaling-up ART is the emergence HIV drug resistance (HIVDR), suggesting the need for pragmatic approaches in sustaining a successful ART performance. METHODS: A survey was conducted in 15 ART sites of the Centre and Littoral regions of Cameroon in 2013 (10 urban versus 05 rural settings; 8 at tertiary/secondary versus 7 at primary healthcare levels), evaluating HIVDR-early warning indicators (EWIs) as-per the 2012 revised World Health Organization’s guidelines: EWI(1) (on-time pill pick-up), EWI(2) (retention in care), EWI(3) (no pharmacy stock-outs), EWI(4) (dispensing practices), EWI(5) (virological suppression). Poor performance was interpreted as potential HIVDR. RESULTS: Only 33.3% (4/12) of sites reached the desirable performance for “on-time pill pick-up” (57.1% urban versus 0% rural; p<0.0001) besides 25% (3/12) with fair performance. 69.2% (9/13) reached the desirable performance for “retention in care” (77.8% urban versus 50% rural; p=0.01) beside 7.7% (1/13) with fair performance. Only 14.4% (2/13) reached the desirable performance of “no pharmacy stock-outs” (11.1% urban versus 25% rural; p=0.02). All 15 sites reached the desirable performance of 0% “dispensing mono- or dual-therapy”. Data were unavailable to evaluate “virological suppression” due to limited access to viral load testing (min-max: <1%-15%). Potential HIVDR was higher in rural (57.9%) compared to urban (27.8%) settings, p=0.02; and at primary (57.9%) compared to secondary/tertiary (33.3%) healthcare levels, p=0.09. CONCLUSIONS: Delayed pill pick-up and pharmacy stock-outs are major factors favoring HIVDR emergence, with higher risks in rural settings and at primary healthcare. Retention in care appears acceptable in general while ART dispensing practices are standard. There is need to support patient-adherence to pharmacy appointments while reinforcing the national drug supply system. Public Library of Science 2015-06-17 /pmc/articles/PMC4471113/ /pubmed/26083364 http://dx.doi.org/10.1371/journal.pone.0129210 Text en © 2015 Fokam et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Fokam, Joseph
Elat, Jean-Bosco N.
Billong, Serge C.
Kembou, Etienne
Nkwescheu, Armand S.
Obam, Nicolas M.
Essiane, André
Torimiro, Judith N.
Ekanmian, Gatien K.
Ndjolo, Alexis
Shiro, Koulla S.
Bissek, Anne C. Z-K.
Monitoring HIV Drug Resistance Early Warning Indicators in Cameroon: A Study Following the Revised World Health Organization Recommendations
title Monitoring HIV Drug Resistance Early Warning Indicators in Cameroon: A Study Following the Revised World Health Organization Recommendations
title_full Monitoring HIV Drug Resistance Early Warning Indicators in Cameroon: A Study Following the Revised World Health Organization Recommendations
title_fullStr Monitoring HIV Drug Resistance Early Warning Indicators in Cameroon: A Study Following the Revised World Health Organization Recommendations
title_full_unstemmed Monitoring HIV Drug Resistance Early Warning Indicators in Cameroon: A Study Following the Revised World Health Organization Recommendations
title_short Monitoring HIV Drug Resistance Early Warning Indicators in Cameroon: A Study Following the Revised World Health Organization Recommendations
title_sort monitoring hiv drug resistance early warning indicators in cameroon: a study following the revised world health organization recommendations
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471113/
https://www.ncbi.nlm.nih.gov/pubmed/26083364
http://dx.doi.org/10.1371/journal.pone.0129210
work_keys_str_mv AT fokamjoseph monitoringhivdrugresistanceearlywarningindicatorsincameroonastudyfollowingtherevisedworldhealthorganizationrecommendations
AT elatjeanboscon monitoringhivdrugresistanceearlywarningindicatorsincameroonastudyfollowingtherevisedworldhealthorganizationrecommendations
AT billongsergec monitoringhivdrugresistanceearlywarningindicatorsincameroonastudyfollowingtherevisedworldhealthorganizationrecommendations
AT kembouetienne monitoringhivdrugresistanceearlywarningindicatorsincameroonastudyfollowingtherevisedworldhealthorganizationrecommendations
AT nkwescheuarmands monitoringhivdrugresistanceearlywarningindicatorsincameroonastudyfollowingtherevisedworldhealthorganizationrecommendations
AT obamnicolasm monitoringhivdrugresistanceearlywarningindicatorsincameroonastudyfollowingtherevisedworldhealthorganizationrecommendations
AT essianeandre monitoringhivdrugresistanceearlywarningindicatorsincameroonastudyfollowingtherevisedworldhealthorganizationrecommendations
AT torimirojudithn monitoringhivdrugresistanceearlywarningindicatorsincameroonastudyfollowingtherevisedworldhealthorganizationrecommendations
AT ekanmiangatienk monitoringhivdrugresistanceearlywarningindicatorsincameroonastudyfollowingtherevisedworldhealthorganizationrecommendations
AT ndjoloalexis monitoringhivdrugresistanceearlywarningindicatorsincameroonastudyfollowingtherevisedworldhealthorganizationrecommendations
AT shirokoullas monitoringhivdrugresistanceearlywarningindicatorsincameroonastudyfollowingtherevisedworldhealthorganizationrecommendations
AT bissekanneczk monitoringhivdrugresistanceearlywarningindicatorsincameroonastudyfollowingtherevisedworldhealthorganizationrecommendations